Multimodality local ablative therapy of 23 lung metastases with surgical resection and percutaneous cryoablation in a patient with Li-Fraumeni Syndrome: A case report
Document Type
Article
Publication Title
Radiology case reports
Abstract
Patients with Li-Fraumeni syndrome (LFS) are prone to develop a variety of malignancies due to insufficient activity of the encoded tumor suppressor protein P53, including adrenocortical carcinoma, breast cancer, lung cancer, pancreatic cancer, and sarcoma. In the setting of LFS, local treatment options for lung metastases are limited to surgery and thermal ablation since radiotherapy and some systemic therapies predispose patients to additional future malignancies. We present the case of a 45-year-old woman with LFS with leiomyosarcoma metastases to both lungs who underwent bilateral wedge resections to treat a total of eight lung metastases followed by six percutaneous cryoablation sessions to treat 15 additional lung metastases over a period of 24 months. Our case demonstrates the option of multimodal local ablative therapies for lung metastases in patients with LFS, including percutaneous cryoablation.
First Page
3586
Last Page
3591
DOI
10.1016/j.radcr.2023.07.047
Publication Date
10-1-2023
Recommended Citation
Saenger, Jonathan A.; Tahir, Ismail; Födinger, Manuela; Cote, Gregory M.; Muniappan, Ashok; and Fintelmann, Florian J., "Multimodality local ablative therapy of 23 lung metastases with surgical resection and percutaneous cryoablation in a patient with Li-Fraumeni Syndrome: A case report" (2023). Radiology. 5.
https://scholar.bridgeporthospital.org/radiology/5
Identifier
37577077 (pubmed); PMC10415826 (pmc); 10.1016/j.radcr.2023.07.047 (doi); S1930-0433(23)00488-0 (pii)